LCTX vs VTYX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTYX Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while LCTX counters with relative strength in Valuation. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus VTYX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LCTX sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LCTX | VTYX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $207.4M | $1.0B | Larger Scale | VTYX |
| Trailing P/E Ratio Valuation | 30.7x | N/M | Lower Multiple | LCTX |
| Forward P/E Ratio Valuation | 30.7x | N/M | Lower Multiple | LCTX |
| Revenue Growth (YoY) Growth | -61.0% | +0.0% | Higher Growth | VTYX |
| Operating Margin (TTM) Profitability | -280.3% | 0.0% | Higher Margin | VTYX |
| Net Profit Margin Profitability | 16.2% | 0.0% | Higher Margin | LCTX |
| Return on Equity (ROE) Capital Efficiency | 4.3% | -45.4% | Higher ROE | LCTX |
| 52-Week Range Position Momentum | 0% ($1โ$2) | 55% ($1โ$25) | Stronger Trend | VTYX |
| Beta / 30D Volatility Risk Regime | 1.39ฮฒ ยท 79% Vol | 2.07ฮฒ ยท 2% Vol | Lower Realized Risk | VTYX |
| Unified Institutional Score Composite Signal | 54.9 / 100 (HOLD) | 50.4 / 100 (HOLD) | Higher Composite | LCTX |